Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis
The implementation of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has been attaining remarkable therapeutic outcomes for CF, a life-threatening autosomal recessive genetic disease. However, there is elevated CFTR allelic heterogeneity, and v...
Main Authors: | Mafalda Bacalhau, Mariana Camargo, Miquéias Lopes-Pacheco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/14/1/93 |
Similar Items
-
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
by: Mafalda Bacalhau, et al.
Published: (2023-03-01) -
miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes
by: Cecilia Bica, et al.
Published: (2024-06-01) -
Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis
by: Beomsu Shin, et al.
Published: (2023-08-01) -
Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
by: Marianna D’Anca, et al.
Published: (2021-07-01) -
Diagnostic potential of exosomal extracellular vesicles in oncology
by: Mickensone Andre, et al.
Published: (2024-03-01)